Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Testing the Safety and Effects of TUB-030 in Patients with Advanced Head and Neck Cancer or Non-Small-Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    France Romania Spain
  • A study testing the reduction of heart failure drug combination in patients with heart failure in remission

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium
  • A Study Comparing DZD8586 to Other Treatments for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded

    Recruiting

    3 1 1 1
    Italy Poland
  • A Study of Gene Replacement Therapy for Children with CTNNB1 Syndrome Using Adeno-Associated Viral Vector Serotype 9 Containing the Human CTNNB1 Gene

    Recruiting

    2 1 1
    Investigated Diseases:
    Slovenia
  • A Study of Botulinum Toxin Type A for Preparing the Abdominal Wall Before Surgery in Patients with Large Complex Hernias

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study of Autologous Tumor-Infiltrating Lymphocytes with Cyclophosphamide, Fludarabine and Aldesleukin in Patients with Germ Cell Tumors

    Recruiting

    2 1 1 1
    Spain
  • A Study Testing Cabergoline to Prevent and Treat Episodic Migraine in Patients with Recurring Migraine Headaches

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • A Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress

    Recruiting

    2 1 1
    Bulgaria Czechia Germany Hungary Poland Romania +1
  • A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer

    Recruiting

    3 1 1 1
    France Germany Spain
  • A Study of Datopotamab Deruxtecan for Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer That Did Not Respond to Hormone Therapy

    Recruiting

    2 1 1
    Investigated Drugs:
    France Italy Spain